Fish-oil supplementation decreases Indoleamine-2,3-Dioxygenase expression and increases hippocampal serotonin levels in the LPS depression model

Behav Brain Res. 2020 Jul 15:390:112675. doi: 10.1016/j.bbr.2020.112675. Epub 2020 May 12.

Abstract

Aim: To test the hypothesis that the antidepressant-like effect of omega-3 polyunsaturated fatty acids is related to the Indoleamine-2,3-Dioxygenase (IDO) inhibition.

Methods: Animals were supplemented for 50 days with 3.0 g/kg of Fish Oil (FO) or received water (Control group - C), via gavage. At the end of this period, both groups were injected with LPS 24 h before the modified forced swim test (MFST) and the open field. To assess the possible involvement of IDO in the FO effects, we performed two independent experiments, using two IDO inhibitors: the direct inhibitor 1-methyl-DL-tryptophan (1-MT) and the anti-inflammatory drug minocycline (MINO), administered 23 h, 5 h and 1 h before the tests. After the tests, the animals' hippocampi were removed for quantification of serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) by HPLC, and for IDO expression by western blot.

Results: LPS induced a depressive-like state in the animals, and this effect was blocked by 1-MT, MINO and FO. Regardless of IDO inhibition, FO supplemented animals displayed an antidepressant-like response by increasing swimming and decreasing immobility frequencies in the MFST when compared to the control group. The immune challenge induced an over-expression of IDO and reduced hippocampal 5-HT levels, both of which were reversed by MINO and FO.

Conclusion: FO induced a pronounced antidepressant-like effect and prevented LPS-induced depressive-like behavior, and this effect was related to decreased IDO expression and increased 5-HT levels in the hippocampus.

Keywords: 1-MT; Depression; Lipopolysaccharide; Minocycline; Omega-3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology*
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / pharmacology*
  • Behavior, Animal / drug effects
  • Depression / chemically induced
  • Depression / metabolism*
  • Depression / prevention & control*
  • Dietary Supplements
  • Fatty Acids, Omega-3 / pharmacology
  • Fish Oils / administration & dosage
  • Fish Oils / pharmacology*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism*
  • Indoleamine-Pyrrole 2,3,-Dioxygenase* / antagonists & inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase* / drug effects
  • Indoleamine-Pyrrole 2,3,-Dioxygenase* / metabolism
  • Lipopolysaccharides / pharmacology
  • Male
  • Minocycline / administration & dosage
  • Minocycline / pharmacology*
  • Rats
  • Rats, Wistar
  • Serotonin / metabolism*
  • Tryptophan / administration & dosage
  • Tryptophan / pharmacology*

Substances

  • 1-methyl-L-tryptophan
  • Anti-Inflammatory Agents
  • Antidepressive Agents
  • Fatty Acids, Omega-3
  • Fish Oils
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Lipopolysaccharides
  • Serotonin
  • Tryptophan
  • Minocycline